Publicaciones en las que colabora con FATIMA GALAN SANCHEZ (100)

2024

  1. Antibiotic use and outcome in patients with negative blood cultures, a new target population for antimicrobial stewardship interventions: A prospective multicentre cohort (NO-BACT)

    Journal of Infection, Vol. 88, Núm. 2, pp. 95-102

  2. Catheter-related bacteremia of rare etiology

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 42, Núm. 2, pp. 108-109

  3. Whole-genome characterisation of Escherichia coli isolates from patients with bacteraemia presenting with sepsis or septic shock in Spain: a multicentre cross-sectional study

    The Lancet Microbe, Vol. 5, Núm. 4, pp. e390-e399

2023

  1. Conventional Hospitalization versus Sequential Outpatient Parenteral Antibiotic Therapy for Staphylococcus aureus Bacteremia: Post-Hoc Analysis of a Multicenter Observational Cohort

    Antibiotics, Vol. 12, Núm. 1

  2. Enteroaggregative Escherichia coli as etiological agent of endemic diarrhea in Spain: A prospective multicenter prevalence study with molecular characterization of isolates

    Frontiers in Microbiology, Vol. 14

  3. Expression profile of microRNAs related with viral infectivity, inflammatory response, and immune activation in people living with HIV

    Frontiers in Microbiology, Vol. 14

  4. Molecular characterization of consecutive isolates of OXA-48-producing Klebsiella pneumoniae: changes in the virulome using next-generation sequencing (NGS)

    Microbes and Infection, Vol. 25, Núm. 8

  5. Pseudomonas aeruginosa antibiotic susceptibility profiles, genomic epidemiology and resistance mechanisms: a nation-wide five-year time lapse analysis

    The Lancet Regional Health - Europe, Vol. 34

  6. Simultaneous and divergent evolution of resistance to cephalosporin/β-lactamase inhibitor combinations and imipenem/relebactam following ceftazidime/avibactam treatment of MDR Pseudomonas aeruginosa infections

    The Journal of antimicrobial chemotherapy, Vol. 78, Núm. 5, pp. 1195-1200

  7. The CARBA-MAP study: national mapping of carbapenemases in Spain (2014–2018)

    Frontiers in Microbiology, Vol. 14

2022

  1. Activity of cefiderocol, imipenem/relebactam, cefepime/taniborbactam and cefepime/zidebactam against ceftolozane/tazobactam- and ceftazidime/avibactam-resistant Pseudomonas aeruginosa

    The Journal of antimicrobial chemotherapy, Vol. 77, Núm. 10, pp. 2809-2815

  2. Fourier transform infrared spectroscopy as a new tool for surveillance in local stewardship antimicrobial program: a retrospective study in a nosocomial Acinetobacter baumannii outbreak

    Brazilian Journal of Microbiology

  3. Hepatitis C: Problems to extinction and residual hepatic and extrahepatic lesions after sustained virological response

    World Journal of Hepatology, Vol. 14, Núm. 1, pp. 62-79

  4. Pseudomonas aeruginosa Community-Onset Bloodstream Infections: Characterization, Diagnostic Predictors, and Predictive Score Development—Results from the PRO-BAC Cohort

    Antibiotics, Vol. 11, Núm. 6

  5. Risk Factors and Predictive Score for Bacteremic Biliary Tract Infections Due to Enterococcus faecalis and Enterococcus faecium: a Multicenter Cohort Study from the PROBAC Project

    Microbiology spectrum, Vol. 10, Núm. 4, pp. e0005122

  6. Transmission of toxigenic Clostridiodes difficile between a pet dog with diarrhea and a 10-month-old infant

    Anaerobe, Vol. 74

2021

  1. Do specific antimicrobial stewardship interventions have an impact on carbapenem resistance in Gram-negative bacilli? A multicentre quasi-experimental ecological study: time-trend analysis and characterization of carbapenemases

    The Journal of antimicrobial chemotherapy, Vol. 76, Núm. 7, pp. 1928-1936

  2. Epidemiologic changes in bloodstream infections in Andalucía (Spain) during the last decade

    Clinical Microbiology and Infection, Vol. 27, Núm. 2, pp. 283.e9-283.e16

  3. Molecular mechanisms driving the in vivo development of OXA-10-mediated resistance to ceftolozane/tazobactam and ceftazidime/avibactam during treatment of XDR Pseudomonas aeruginosa infections

    The Journal of antimicrobial chemotherapy, Vol. 76, Núm. 1, pp. 91-100

  4. Predicting Pseudomonas aeruginosa susceptibility phenotypes from whole genome sequence resistome analysis

    Clinical Microbiology and Infection, Vol. 27, Núm. 11, pp. 1631-1637